The Asia Pacific Digital Therapeutics Market would witness market growth of 23.2% CAGR during the forecast period (2021-2027). Digital therapeutics refers to healthcare solution and treatment option, which uses digital technologies to cure patients with any kind of medical or psychological problem. It offers a whole new approach for the treatment and disease management under which it uses systems & high-quality software to assist patients to monitor their health conditions at home.
In addition, these solutions use internet infrastructure, smartphones, and certain advanced technologies like artificial intelligence (AI), machine learning, and big data analytics to maximize the treatment for a patient, thus implementing the principle of customized medicine. The digital therapeutics market consists of a wide variety of products like telemedicine platforms, apps, wearable devices, and others. In present scenario, there are many healthcare apps and wearable devices which are easily accessible all over the world.
Advancements in technologies in developing countries are estimated to spur the demand for the digital therapeutics market. It is due to the increasing disposable income, use of the internet, and mobile & other smart devices. In addition, a rising number of healthcare applications and wearable gadgets have contributed to connecting the world via a different range of applications. All these technological improvements will further open new growth avenues for the digital therapeutics market during the forecast period. Moreover, the increasing government initiatives & programs to protect the healthy population are also expected to support the demand for the digital therapeutics market over the years. Developing countries are adopting various technological advancements that further help the market to grow.
The Diabetes market dominated the South Korea Digital Therapeutics Market by Applications 2020, thereby, achieving a market value of $90.2 million by 2027. The CNS Disease market is estimated to grow at a CAGR of 27% during (2021 - 2027). The Respiratory Diseases market is showcasing a CAGR of 28.3% during (2021 - 2027). Additionally, The Smoking Cessation market is expected to witness a CAGR of 27.7% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Digital Therapeutics Market is Projected to reach USD 14.5 Billion by 2027, at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
By End Use
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
